Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

China flag China · Delayed Price · Currency is CNY
7.34
+0.02 (0.27%)
Jan 22, 2026, 3:00 PM CST
20.13%
Market Cap12.20B
Revenue (ttm)16.62B
Net Income (ttm)1.28B
Shares Out1.66B
EPS (ttm)0.77
PE Ratio9.52
Forward PE9.66
Dividend0.38 (5.19%)
Ex-Dividend DateJun 23, 2025
Volume25,813,116
Average Volume26,026,533
Open7.30
Previous Close7.32
Day's Range7.29 - 7.36
52-Week Range5.91 - 8.55
Beta0.26
RSI66.34
Earnings DateMar 17, 2026

About SHA:600866

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroyi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 9,293
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600866
Full Company Profile

Financial Performance

In 2024, SHA:600866's revenue was 17.33 billion, a decrease of -0.23% compared to the previous year's 17.37 billion. Earnings were 943.15 million, an increase of 39.12%.

Financial Statements